Stay updated on NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Footer revision updated from v3.3.3 to v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-14T04:01:18.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer.
    Difference
    0.1%
    Check dated 2025-12-23T21:21:30.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision numbers in the page footer were updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T10:53:07.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Removed a general government funding and operating status notice that previously appeared on the page header. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T06:55:15.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    UI update to the Record History page shows an extended list of submission versions for NCT03635983, adding more version entries and updated navigation. No changes to the trial data, status, or results are observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-03T21:04:32.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    Major update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.
    Difference
    8%
    Check dated 2025-10-06T05:29:16.000Z thumbnail image

Stay in the know with updates to NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial page.